Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Northstar Neuroscience |
---|---|
Information provided by: | Northstar Neuroscience |
ClinicalTrials.gov Identifier: | NCT00170703 |
The primary objective of this feasibility study is to evaluate the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with speech-language rehabilitation activities to enhance recovery in study subjects suffering from Broca's aphasia (the inability to speak or to organize the muscular movements for speech), following a stroke.
Condition | Intervention | Phase |
---|---|---|
Stroke Broca's Aphasia |
Device: Cortical Electrical Stimulation |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Assessment of the Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Speech-Language Rehabilitation to Enhance Recovery in Patients Suffering From Broca's Aphasia, Following a Stroke. |
Estimated Enrollment: | 8 |
Study Start Date: | December 2004 |
Study Completion Date: | September 2007 |
Stroke is the third leading cause of death and the most common cause of disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. Approximately 150,000 to 250,000 stroke survivors becoming severely and permanently disabled each year.
A common neurological deficit among these stroke survivors, and thus a substantial contributor to post-stroke disability is Broca's aphasia, a condition in which the patient is unable to speak normally, as they cannot effectively organize the muscular movements required for speech. Broca's aphasia is often referred to as "non-fluent" or "motor" aphasia as essentially the patient has impaired motor abilities for speech and thus, become non-fluent in speech/language. The loss of speech for these patients is extremely debilitating and has enormous social and economic impact to the quality of life for these patients. Presently, the only treatment available for patients with Broca's aphasia is speech-language rehabilitation. However, with rehabilitation only, many patients achieve a less than satisfactory improvement in speech-language function and thus, are left with significant disability.
Since Broca's aphasia is largely due to an impairment of language-related motor function, researchers and clinicians believe it is very likely that cortical stimulation in conjunction with speech rehabilitation may also enhance recovery of language motor function for Broca's aphasia patients. This study proposes to evaluate the safety and effectiveness of such cortical electrical stimulation in study subjects with Broca's aphasia after stroke, delivered concurrent with speech-language rehabilitation.
In addition to evaluating changes from baseline level, safety and efficacy measures will be compared to patients who undergo the same speech-language rehabilitation activities but without cortical stimulation. The two study groups will be compared to determine the degree to which the aphasia can be improved beyond rehabilitation alone by epidural stimulation of a targeted cortical region.
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | V0325 |
Study First Received: | September 12, 2005 |
Last Updated: | September 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00170703 |
Health Authority: | United States: Food and Drug Administration |
Cortical Electrical Stimulation Ischemic Stroke Broca's Aphasia Speech Rehabilitation Functional MRI |
Speech Disorders Cerebral Infarction Aphasia Aphasia, Broca Stroke Vascular Diseases Central Nervous System Diseases Language Disorders |
Ischemia Brain Diseases Cerebrovascular Disorders Signs and Symptoms Neurologic Manifestations Neurobehavioral Manifestations Communication Disorders |
Nervous System Diseases Cardiovascular Diseases |